![Jean-Pierre Garnier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Pierre Garnier
Patrimonio netto: 956 932 $ in data 31/12/2025
Profilo
Jean-Pierre Garnier è un uomo d'affari francese che è stato a capo di 14 diverse aziende e attualmente occupa la posizione di presidente non esecutivo di Cellectis SA e di presidente di Carmat SA. Il Dr. Garnier è anche nel consiglio di amministrazione di Radius Health, Inc., Max Planck Institute For Biophysical Chemistry e Carrier Global Corp. e Operating Partner di Advent International LLC. In precedenza è stato presidente di NormOxys, Inc., presidente di Alzheon, Inc., presidente di ABIONYX Pharma SA e presidente di Cerenis Therapeutics, Inc. (una filiale di ABIONYX Pharma SA), presidente di Idorsia Ltd., presidente di Idorsia Pharmaceuticals Ltd., amministratore delegato di GlaxoSmithKline Plc e amministratore delegato di Smithkline Beecham Plc (una filiale di GlaxoSmithKline Plc), presidente di e.Nvizion Communications Group Ltd., direttore di Actelion Ltd., amministratore delegato di Pierre Fabre SA, presidente di Schering-Plough Corp. e consigliere di Quaker Partners Management LP. Il Dr. Garnier ha ricevuto un MBA dall'Università di Stanford e un dottorato e una laurea all'Università Louis Pasteur.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 09/04/2025 | 18.110 ( 0% ) | 956 932 $ | 31/12/2025 | |
CELLECTIS S.A. -.--% | 15/02/2025 | 0 ( -.--% ) | - $ | 31/12/2025 |
BIOAGE LABS, INC. -.--% | 05/06/2025 | 0 ( -.--% ) | - $ | 31/12/2025 |
Posizioni attive di Jean-Pierre Garnier
| Società | Posizione | Inizio |
|---|---|---|
| CARRIER GLOBAL CORPORATION | Direttore/Membro del Consiglio | 03/04/2020 |
| CELLECTIS S.A. | Presidente | 05/11/2020 |
| BIOAGE LABS, INC. | Presidente | 20/08/2024 |
Carrier Corp.
 Carrier Corp. Industrial MachineryProducer Manufacturing Manufactures air conditioning, heating & refrigeration equipment | Direttore/Membro del Consiglio | - |
Advent International LLC
 Advent International LLC Investment ManagersFinance Provides risk capital and investments | Corporate Officer/Principal | - |
Precedenti posizioni note di Jean-Pierre Garnier
| Società | Posizione | Fine |
|---|---|---|
| CARMAT | Presidente | 22/12/2022 |
| RADIUS HEALTH, INC. | Direttore/Membro del Consiglio | 15/08/2022 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Develops and commercializes pharmaceuticals | Presidente | 13/05/2020 |
| IDORSIA LTD | Presidente | 13/05/2020 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jean-Pierre Garnier
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 29 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Manufactures and sells pharmaceutical & health care products | |
United Technologies Corp.
 United Technologies Corp. Manufactures engine parts, elevators, and air-conditioning equipment | |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
e.Nvizion Communications Group Ltd.
 e.Nvizion Communications Group Ltd. Financial ConglomeratesFinance Development stage company | Finance |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Advent International LLC
Advent International LLC Investment ManagersFinance Provides risk capital and investments | Finance |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Newman's Own Foundation
 Newman's Own Foundation Operates as a charity | |
Alzheon, Inc.
 Alzheon, Inc. Develops treatment for brain health, memory and aging | |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renault SA
 Renault SA Motor VehiclesConsumer Durables Manufactures and distributes automobiles and other motor vehicles | Consumer Durables |
Carrier Corp.
Carrier Corp. Industrial MachineryProducer Manufacturing Manufactures air conditioning, heating & refrigeration equipment | Producer Manufacturing |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Participations SAS
 Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology and cosmetic products | Health Technology |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers | Health Technology |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Carmat SA
 Carmat SA Medical SpecialtiesHealth Technology Specializes in the construction of artificial hearts | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max Planck Institute For Biophysical Chemistry
 Max Planck Institute For Biophysical Chemistry Functions as a College/University | |
Max Planck Florida Institute for Neuroscience
 Max Planck Florida Institute for Neuroscience Researches and develops on neuroscience | |
BioAge Labs, Inc.
 BioAge Labs, Inc. Develops therapies obesity for metabolic diseases | |
Idorsia Ltd.
 Idorsia Ltd. Engages in the discovery, development and commercialization of medicines for unmet medical needs | |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Develops and commercializes pharmaceuticals | |
Carrier Global Corp.
 Carrier Global Corp. Manufactures, sells and installs HVAC, refrigeration, fire and security solutions | |
Louis Pasteur University
 Louis Pasteur University Functions as a College/University |
